µµ¼­Á¤º¸
Á¦¸ñ °¡Àӷº¸Á¸
ÀúÀÚ ´ëÇÑ°¡Àӷº¸Á¸ÇÐȸ
¿ªÀÚ
ÃâÆÇ»ç ±ºÀÚÃâÆÇ»ç
ISBN 9791159557460
ÃâÆÇÀÏ 2021³â 9¿ù 26ÀÏ
ÆÇÇü B5
ÆäÀÌÁö¼ö 348ÂÊ
ÆǸŰ¡°Ý 80,000¿ø
 Information

ÀÌ Ã¥Àº Áö±Ý±îÁöÀÇ °¡Àӷº¸Á¸ ºÐ¾ß ¹ßÀü¿¡ ¹ß¸ÂÃß¾î °¡Àӷº¸Á¸ÀÇ ¿ª»ç¿¡¼­ºÎÅÍ ÃÖ½ÅÀÇ ¿¬±¸°á°úµé±îÁö ü°èÀûÀ¸·Î Á¤¸®ÇÏ¿© ±¹³» ÃÖÃÊÀÇ °¡Àӷº¸Á¸ ±³°ú¼­·Î¼­ ÀÌ ºÐ¾ß¸¦ °øºÎÇÏ°íÀÚ ÇÏ´Â ÀÇ°ú´ëÇлý, ¼ö·ÃÀǻӸ¸ ¾Æ´Ï¶ó °¡Àӷº¸Á¸ ȯÀÚ¸¦ ¸¸³ª´Â ¿©·¯ ÀÇ·á ÇöÀåÀÇ ÀÇ·áÀε鿡°Ô ´Ù°¢µµÀÇ Á¤º¸¿Í Àü¹® Áö½ÄÀ» Á¦°øÇÏ°íÀÚ ÇÏ¿´½À´Ï´Ù.

 Contents

SECTION 1 °¡Àӷº¸Á¸ °³·Ð(Introduction)

CHAPTER 01 °¡Àӷº¸Á¸ÀÇ ¿ª»ç: º¸Á¶»ý½Ä¼ú·ÎºÎÅÍ °¡Àӷº¸Á¸±îÁö(History: from ART to fertility preservation)
1. º¸Á¶»ý½Ä¼úÀÇ ¿ª»ç
2. °¡Àӷº¸Á¸ÀÇ ¹ßÀü
3. ±¹³»/±¹¿Ü °¡Àӷº¸Á¸ °ü·Ã ÇÐȸ
References

CHAPTER 02 ¾ÏÄ¡·á¿Í °¡ÀÓ·Â(The effect of cancer therapy on reproductive function)
1. ¾ÏÄ¡·á¿Í °¡Àӷº¸Á¸ÀÇ Á߿伺
2. ¾ÏÄ¡·á°¡ °¡Àӷ¿¡ ¹ÌÄ¡´Â ¿µÇâ
3. °¢Á¾ ¾ÏÄ¡·á°¡ °¡Àӷ¿¡ ¹ÌÄ¡´Â ¿µÇâ
4. ¼Ò°á
References

CHAPTER 03 ¾ç¼º Áúȯ¿¡¼­ÀÇ °¡Àӷº¸Á¸(Fertility preservation in non-cancer patients)
1. ³ªÀÌ¿Í °¡ÀÓ·Â
2. °¡Àӷº¸Á¸À» °í·ÁÇÒ ¼ö ÀÖ´Â ¾ç¼º Áúȯ
References

CHAPTER 04 °¡Àӷº¸Á¸À» À§ÇÑ ³­¼Ò±â´É Æò°¡(Ovarian reserve test for fertility preservation)
1. ÀÌÇÐÀû ³»ºÐºñ °Ë»ç ¹× À¯¹ß°Ë»ç(Laboratory endocrine assessment and dynamic testing)
2. À¯¹ß°Ë»ç(Dynamic tests of ovarian reserve)
3. ÃÊÀ½ÆÄ ÁöÇ¥(Ultrasound parameters)
4. ³ªÀÌ(Age)
References

CHAPTER 05 µ¿°á»ý¹°ÇÐ(Cryobiology)
1. ¹°ÀÇ µ¿°á
2. µ¿°á¼Õ»ó(cryodamage) ±âÀü
3. ¿Ï¸¸µ¿°á
4. À¯¸®È­µ¿°á
5. µ¿°áº¸È£Á¦
6. µ¿°á-Çص¿ ÇÁ·Î±×·¥ÀÇ »ý½ÄÀÇÇÐºÐ¾ß Àû¿ë°ú °í·Á ¿äÀÎ
7. µ¿°á-Çص¿ ÇÁ·Î±×·¥ÀÇ ÀáÀçÀû À§Ç輺 °íÂû
References

SECTION 2 °¡Àӷº¸Á¸ Ä¡·á(Fertility Preservation Treatments)

CHAPTER 06 °¡Àӷº¸Á¸À» À§ÇÑ °ú¹è¶õÀ¯µµ(Ovarian stimulation protocol for fertility preservation)
1. ¼­·Ð
2. ÀþÀº ¿©¼º À¯¹æ¾Ï ȯÀÚÀÇ À¯ÀüÇÐÀû, ÀÓ»óÀû ¾ç»ó
3. °¡Àӷº¸Á¸À» À§ÇÑ ³­¼ÒÀÚ±Ø: ¡°Going beyond physiological standards¡±
4. °á·Ð
References

CHAPTER 07 ³­ÀÚ¿Í ¹è¾Æ µ¿°áº¸Á¸(Cryopreservation of oocyte and embryo)
1. ¼­·Ð(Introduction)
2. °¡Àӷº¸Á¸ Ä¡·áÀÇ ÀûÀÀÁõ(Candidates for fertility preservation)
3. ¹è¾Æ µ¿°áº¸Á¸(Embryo cryopreservation)
4. ³­ÀÚ µ¿°áº¸Á¸(Oocyte cryopreservation)
5. ¼¼ºÎÀû °í·Á»çÇ×(Specific considerations)
6. °á·Ð(Conclusion)
References

CHAPTER 08 ³­¼Ò Á¶Á÷ µ¿°áº¸Á¸°ú À̽Ä(Ovarian tissue cryopreservation and transplantation)
1. ³­¼Ò Á¶Á÷ µ¿°á-Çص¿ ¹× ÀÌ½Ä ½Ã °¡À̵å¶óÀÎ
2. ³­ÀÚ ¶Ç´Â ¹è¾Æ µ¿°á¹ý°úÀÇ Â÷ÀÌÁ¡
3. ³­¼Ò Á¶Á÷ÀÇ È¹µæ, µ¿°á, ÀÌ½Ä ¹æ¹ý
4. ³­¼Ò Á¶Á÷ µ¿°á-Çص¿ ¹× À̽İú °ü·ÃÇÏ¿© ÇØ°áÇØ¾ß ÇÒ °úÁ¦µé
5. Çѱ¹¿¡¼­ÀÇ µ¿°á-Çص¿ ³­¼Ò ÀÌ½Ä ¹× ü¿Ü¼öÁ¤ ½Ã¼ú·Ê
6. Àüü ³­¼Ò µ¿°áº¸Á¸ ¹× À̽Ä(Whole ovary transplantation)
7. ¸ÎÀ½¸»
References

CHAPTER 09 ¹Ì¼º¼÷³­ÀÚÀÇ Ã¼¿Ü¼º¼÷(In vitro maturation of immature oocyte)
1. °³¿ä ¹× ÀûÀÀÁõ
2. ¹Ì¼º¼÷³­ÀÚ Ã¤Ãë ¹× Ã¼¿Ü¼º¼÷ °úÁ¤
3. IVM ±â¹ýÀÇ ¾ÈÀü¼º
4. °¡Àӷº¸Á¸ Ãø¸é¿¡¼­ÀÇ ¹Ì¼º¼÷³­ÀÚÀÇ ÀÌ¿ë
References

CHAPTER 10 »ý½Ä»ùÀÚ±ØÈ£¸£¸ó¹æÃâ È£¸£¸óÀÛ¿ëÁ¦(GnRH agonist)
1. °³¿ä
2. GnRHa°¡ ³­¼Ò±â´ÉÀ» ¾î¶»°Ô º¸Á¸Çϴ°¡?
3. GnRHaÀÇ È¿°ú¿¡ ´ëÇÑ ±Ù°Å
4. °á·Ð
References

CHAPTER 11 °¡Àӷº¸Á¸¼ö¼ú(Fertility sparing surgery)
1. °³¿ä
2. ³­¼Ò Á¶Á÷ µ¿°áº¸Á¸ ¼ö¼ú ¹× À̽Ä
3. ³­¼Ò Á¶Á÷ äÃë ¹× ¼ö¼úµµ±¸
4. ³­¼Ò Á¶Á÷ ÀÌ½Ä ½Ã ¼ö¼úÀû °í·Á»çÇ×
5. Àüü ³­¼Ò µ¿°áº¸Á¸ ¹× À̽Ä(Whole ovary transplantation)
6. ³­¼Ò Á¶Á÷ µ¿°áº¸Á¸ ¼ö¼ú ¹× À̽ļú ÈÄ ³­¼Ò±â´Éȸº¹
7. ³­¼Ò Á¶Á÷ µ¿°áº¸Á¸ ¼ö¼ú ¹× À̽ļú ÈÄ ÀӽŰá°ú
8. ºÎÀÎÁ¾¾ç ȯÀÚ¿¡ ´ëÇÑ °¡Àӷº¸Á¸ ¼ö¼ú
9. °á·Ð
References

CHAPTER 12 ³²¼º °¡Àӷº¸Á¸(Male fertility preservation)
1. ¼­·Ð
2. ¾ÏÄ¡·á¿Í ³²¼º °¡ÀÓ·Â
3. ¾ÏÄ¡·á Àü ½ÃÇàÇϴ ȣ¸£¸ó¾ïÁ¦Ä¡·á(Hormone suppression before cancer therapy)
4. Á¤Àڳõ¿º¸Á¸(Cryopreservation of spermatozoa)
5. Á¤Á¶Áٱ⼼Æ÷¿Í »ý½Ä¼¼Æ÷ÀÇ ³Ãµ¿º¸Á¸ ¹× À̽Ä(Cryopreservation and transplantation of spermatogonial stem cell and germ cell)
6. °íȯÁ¶Á÷³Ãµ¿º¸Á¸ ¹× À̽Ä
7. °á·Ð
References

SECTION 3 °¡Àӷº¸Á¸ ȯÀÚÀÇ °ü¸®(Care of Fertility Preservation Patients)

CHAPTER 13 °¡Àӷº¸Á¸ Ä¡·áÀÇ Á¦°ø(Organization of fertility presercation care)
1. ¾ÏȯÀÚÀÇ °¡Àӷº¸Á¸ ÀÇ»ç°áÁ¤¿¡ ¾î·Á¿òÀ» ÁÖ´Â ¿ä¼Ò
2. ÇöÀç °¡Àӷº¸Á¸ ÇÁ·Î±×·¥ÀÇ ÇÑ°è
3. ¼º°øÀûÀÎ °¡Àӷº¸Á¸ ÇÁ·Î±×·¥À» À§ÇÑ ¹æ¹ý
4. ºÎÀξÏȯÀÚ¸¦ À§ÇÑ °¡Àӷº¸Á¸ÀÇ Æ¯º° °í·Á »çÇ×
References

CHAPTER 14 °¡Àӷº¸Á¸ ÈÄ ³­ÀÓ Ä¡·á(Fertility treatment after fertility preservation)
1. °¡Àӷº¸Á¸ ÈÄ ³­ÀÓ Ä¡·á ¼º°ø·ü
2. °á·Ð
References

CHAPTER 15 »ê°úÀû °á°ú ¹× °ü¸®(Obstetric outcomes and care)
1. ¾Ï »ýÁ¸ÀÚÀÇ Àӽſ¡ ¾ÏÀÌ ¹ÌÄ¡´Â ¿µÇâ(Effect of cancer on survivor¡¯s pregnancy)
2. ÇâÈÄ ÀӽŠ°á°ú¿¡ Ç×¾ÏÄ¡·á ¹× ¹æ»ç¼±Ä¡·á°¡ ¹ÌÄ¡´Â ¿µÇâ(Effect of chemotherapy and radiotherapy on future obstetric outcomes)
3. °¡Àӷº¸Á¸ Ä¡·áÀÇ ÀӽŠ°á°ú(Obstetric outcomes of fertility preservation treatment)
4. ¾Ï »ýÁ¸ÀÚ ÀӽŠ¹× °¡Àӷº¸Á¸ Ä¡·á ÈÄ ÀӽŠ½ÃÀÇ °ü¸®(Management of pregnancy in cancer survivor or pregnancy after fertility preservation treatment)
References

CHAPTER 16 °¡Àӷº¸Á¸ÀÇ À±¸®Àû °í·Á(Ethical considerations in fertility preservation)
1. ¾ÏȯÀÚÀÇ ¼±ÅÃ(Patient¡¯s dilemma: balancing cancer and fertility)
2. µ¿ÀǼ­(Informed consent)
3. ¼ºÀο¡¼­ÀÇ °¡Àӷº¸Á¸¼ú
4. ¼Ò¾Æ¿¡¼­ÀÇ °¡Àӷº¸Á¸¼ú
5. ¾Ï Ä¡À¯ ÈÄ Ãâ»ê(Cancer surviviors¡¯ reproduce)
6. »çÈÄ µ¿°á ¼¼Æ÷/Á¶Á÷ÀÇ »ç¿ë(Posthumous use of stored reproductive tissue)
7. °á¾î
References

SECTION 4 °¡Àӷº¸Á¸ Ä¡·áÀÇ Àü¸Á(Future Techniques for Fertility Preservation)

CHAPTER 17 °¡Àӷº¸Á¸ Ä¡·áÁ¦(Fertoprotective agents)
1. Ammonium trichloro (dioxoethylene- o,o¡¯) tellurate ; AS101
2. Ceramide-1 Phosphates, C1P
3. Ç׹ķ¯°üÈ£¸£¸ó(Anti-mullerian hormaone, AMH)
4. mTOR inhibitors; ¿¡¹ö·Ñ¸®¹«½º(Everolimus)
5. À̸¶Æ¼´Õ(Imatinib)
6. ¸á¶óÅä´Ñ(Melatonin)
7. Ÿ¸ñ½ÃÆæ(Tamoxifen)
8. ±âŸ ¿¬±¸ ÁßÀÎ ¾à¹°
References

CHAPTER 18 ³­¼Ò±â´ÉÀÇ Àç»ý(Ovarian rejuvenation)
1. ¼­·Ð
2. ³­¼Ò Àç»ý Ä¡·á ÀÓ»ó ¿¬±¸
3. Àü¸Á
References

CHAPTER 19 Àΰø³­¼Ò¿Í »ý½Ä¼¼Æ÷ »ý¼º(Artificial ovary and stem cell technology for germ cell formation)
1. ¿©¼º °¡Àӷº¸Á¸À» À§ÇÑ Àΰø³­¼Ò(Artificial ovary for female fertility preservation)
2. Áٱ⼼Æ÷ À¯·¡ »ý½Ä¼¼Æ÷ÀÇ »ý»ê(Production of germ cells from stem cells)
References

Index


2021-10-10 ¿ÀÈÄ 4:31:37, Á¶È¸¼ö : 617